Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices

Journal of Toxicology. Clinical Toxicology

Abstract

These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.

References

Aug 1, 1991·Vaccine·P C Turnbull
Jan 1, 1991·Scandinavian Journal of Infectious Diseases·M Doğanay, N Aydin
Oct 1, 1989·The Journal of Infectious Diseases·L H HarrisonA F Kaufmann
May 1, 1986·Infection and Immunity·B E IvinsS H Leppla
May 1, 1987·The Journal of Infectious Diseases·D AbdenourM Aouati
Nov 1, 1974·Annals of Internal Medicine·C S WhiteV G McGann
Jun 25, 1971·Science·G B Van Ness
Mar 1, 1966·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·R G Hoffmann, C M Williams
Jan 1, 1983·Infection and Immunity·P MikesellT M Dreier
Jun 1, 1984·Vaccine·P HambletonJ Melling
Jan 1, 1980·Annals of the New York Academy of Sciences·P S Brachman
Jul 14, 1995·Brain Research. Developmental Brain Research·A T Harvey, M B Hennessy
Jul 1, 1994·Radiographics : a Review Publication of the Radiological Society of North America, Inc·C StoupisJ Gauger
Nov 18, 1994·Science·M MeselsonO Yampolskaya
May 1, 1994·Vaccine·R T ChenS G Wassilak
Sep 1, 1994·Annals of Internal Medicine·W E Farrar
May 1, 1993·The Journal of Infectious Diseases·A M FriedlanderP Mikesell
Mar 21, 1998·Archives of Internal Medicine·J C PileA M Friedlander
May 23, 1998·Science·N S DuesberyG F Vande Woude
Jul 11, 1998·Science·P Hanna
Sep 28, 1998·JAMA : the Journal of the American Medical Association·K FukudaW C Reeves
May 18, 1999·JAMA : the Journal of the American Medical Association·T V InglesbyK Tonat
Sep 4, 1999·Journal of Applied Microbiology·M L PittA M Friedlander
Sep 4, 1999·Journal of Applied Microbiology·K FowlerL W Baillie
Sep 9, 1999·The New England Journal of Medicine·T C DixonP C Hanna
Dec 11, 1999·JAMA : the Journal of the American Medical Association·A M FriedlanderG W Parker
Mar 1, 1956·The Journal of Hygiene·D W HENDERSONF C BELTON
Sep 8, 1956·Lancet·F C BELTOND W HENDERSON
Feb 1, 1965·The Journal of Infectious Diseases·M K WARDE O ROBERTS
Jul 1, 1965·Annals of Internal Medicine·R N PEELERL E CLUFF
Apr 1, 1962·American Journal of Public Health and the Nation's Health·P S BrachmanN R Ingraham
Jan 1, 1947·The Journal of Pathology and Bacteriology·J M BARNES

❮ Previous
Next ❯

Citations

Oct 21, 2003·Current Neurology and Neuroscience Reports·M H Han, J R Zunt
Nov 7, 2009·Emerging Infectious Diseases·John A CarnieBruce R Thorley
Dec 21, 2013·Seminars in Fetal & Neonatal Medicine·Sonja A RasmussenDenise J Jamieson
Jan 6, 2012·Journal of Women's Health·Mona SaraiyaCrystale Purvis Cooper
Mar 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lawrence M WeinEdward H Kaplan
Apr 8, 2011·Emerging Infectious Diseases·Gregory E YoungDebra Blog
Apr 8, 2011·Emerging Infectious Diseases·Christine M HughesInger K Damon
Sep 10, 2011·Journal of Pharmaceutical Sciences·Sheena H WangAnthony J Hickey
Aug 22, 2009·BMC Structural Biology·Rafael M CouñagoKurt L Krause
Oct 10, 2007·PLoS Pathogens·Darly J ManayaniAnette Schneemann
Dec 20, 2007·Oral and Maxillofacial Surgery Clinics of North America·Sidney L Bourgeois, Michael J Doherty
Mar 5, 2003·Vaccine·Joanne E EnstoneJames C G Pearson
Dec 1, 2001·Nature Medicine·H C LaneA S Fauci
Dec 26, 2001·Nature Biotechnology·Eric Niiler
Oct 2, 2002·Psychological Reports·Walter R SchummStephan R Bollman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.